Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2016 2
2017 2
2018 4
2019 4
2020 4
2021 4
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Moyamoya disease 5"
Page 1
Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis.
Singh R, Bauman MMJ, Seas A, Harrison DJ, Pennington Z, Brown NJ, Gendreau J, Rahmani R, Ellens N, Catapano J, Lawton MT. Singh R, et al. Neurosurg Rev. 2023 Sep 2;46(1):220. doi: 10.1007/s10143-023-02123-z. Neurosurg Rev. 2023. PMID: 37658996
Despite more than six decades of extensive research, the etiology of moyamoya disease (MMD) remains unknown. Inflammatory or autoimmune (AI) processes have been suggested to instigate or exacerbate the condition, but the data remains mixed. ...Of the 148 patients wh …
Despite more than six decades of extensive research, the etiology of moyamoya disease (MMD) remains unknown. Inflammatory or a …
Direct, Indirect, and Combined Extracranial-to-Intracranial Bypass for Adult Moyamoya Disease: An Updated Systematic Review and Meta-Analysis.
Nguyen VN, Motiwala M, Elarjani T, Moore KA, Miller LE, Barats M, Goyal N, Elijovich L, Klimo P, Hoit DA, Arthur AS, Morcos JJ, Khan NR. Nguyen VN, et al. Stroke. 2022 Dec;53(12):3572-3582. doi: 10.1161/STROKEAHA.122.039584. Epub 2022 Sep 22. Stroke. 2022. PMID: 36134563
BACKGROUND: Moyamoya disease is a chronic, progressive cerebrovascular disease involving occlusion or stenosis of the terminal portion of the internal carotid artery. We conducted an updated systematic review and meta-analysis to investigate clinical and angi …
BACKGROUND: Moyamoya disease is a chronic, progressive cerebrovascular disease involving occlusion or stenosis of the t …
Moyamoya disease in pregnancy: a systematic review.
Maragkos GA, Ascanio LC, Chida K, Boone MD, Ogilvy CS, Thomas AJ, Kasper EM. Maragkos GA, et al. Acta Neurochir (Wien). 2018 Sep;160(9):1711-1719. doi: 10.1007/s00701-018-3597-6. Epub 2018 Jun 19. Acta Neurochir (Wien). 2018. PMID: 29915888
BACKGROUND: Moyamoya disease (MMD) management during pregnancy poses a challenge to health care providers, and recommendations are outdated, vague, and controversial. ...In patients first diagnosed with MMD due to a cerebrovascular accident during pregnancy, the mea …
BACKGROUND: Moyamoya disease (MMD) management during pregnancy poses a challenge to health care providers, and recommendations …
Macrohistory of Moyamoya Disease Analyzed Using Artificial Intelligence.
Kuribara T, Akiyama Y, Mikami T, Komatsu K, Kimura Y, Takahashi Y, Sakashita K, Chiba R, Mikuni N. Kuribara T, et al. Cerebrovasc Dis. 2022;51(4):413-426. doi: 10.1159/000520099. Epub 2022 Feb 1. Cerebrovasc Dis. 2022. PMID: 35104814 Free article.
The objective of this review was to provide a holistic view of the epidemiology, etiology, clinical findings, treatment, and pathogenesis of moyamoya disease. A literature search was performed in PubMed using the term "moyamoya disease," for articles p …
The objective of this review was to provide a holistic view of the epidemiology, etiology, clinical findings, treatment, and pathogenesis of …
Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature.
Strunk D, Bauer P, Keyvani K, Diehl RR, Veltkamp R, Berlit P, Meuth SG, Timmermann L, Schwitalla JC, Kraemer M. Strunk D, et al. J Neurol. 2024 Jun;271(6):3328-3339. doi: 10.1007/s00415-024-12228-0. Epub 2024 Mar 13. J Neurol. 2024. PMID: 38478032 Free PMC article.
BACKGROUND: Moyamoya disease (MMD) is a rare disorder causing ischemic and hemorrhagic juvenile stroke. ...RESULTS: The study cohort comprised 32 Southeast Asians. Mean age at onset in the entire cohort was 32.5 20.3 years (n = 24), 43.4 8.7 years in patients …
BACKGROUND: Moyamoya disease (MMD) is a rare disorder causing ischemic and hemorrhagic juvenile stroke. ...RESULTS: The study …
Surgical revascularizations for pediatric moyamoya: a systematic review, meta-analysis, and meta-regression analysis.
Lee KS, Zhang JJY, Bhate S, Ganesan V, Thompson D, James G, Silva AHD. Lee KS, et al. Childs Nerv Syst. 2023 May;39(5):1225-1243. doi: 10.1007/s00381-023-05868-6. Epub 2023 Feb 8. Childs Nerv Syst. 2023. PMID: 36752913 Free PMC article.
INTRODUCTION: There is no clear consensus regarding the technique of surgical revascularization for moyamoya disease and syndrome (MMD/MMS) in the pediatric population. ...RESULTS: Thirty-seven studies reporting 2460 patients and 4432 hemispheres were included in th …
INTRODUCTION: There is no clear consensus regarding the technique of surgical revascularization for moyamoya disease and syndr …
Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review.
Kleinloog R, Regli L, Rinkel GJ, Klijn CJ. Kleinloog R, et al. J Neurol Neurosurg Psychiatry. 2012 May;83(5):531-6. doi: 10.1136/jnnp-2011-301387. Epub 2012 Feb 29. J Neurol Neurosurg Psychiatry. 2012. PMID: 22378916 Review.
BACKGROUND AND PURPOSE: Moyamoya disease (MMD) is a rare cause of stroke, initially described in Japan. ...Incidences per 100 000 patient years ranged in Japan from 0.35 to 0.94 (95% CI 0.69 to 1.19), in the USA from 0.05 (-0.04 to 0.12) in Iowa to 0.17 (-0.06 to 0. …
BACKGROUND AND PURPOSE: Moyamoya disease (MMD) is a rare cause of stroke, initially described in Japan. ...Incidences per 100 …
Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X, Deng J, Dai W, Zhang T, Yan J. Liao X, et al. Environ Health Prev Med. 2017 Nov 2;22(1):75. doi: 10.1186/s12199-017-0680-1. Environ Health Prev Med. 2017. PMID: 29165161 Free PMC article. Review.
BACKGROUND: The p.R4810K and other rare variants of ring finger protein 213 gene (RNF213) were illustrated as susceptibility variants for moyamoya (MMD) and non-moyamoya intracranial artery stenosis/occlusion disease (ICASO) recently. ...RNF213 p.R4810K also …
BACKGROUND: The p.R4810K and other rare variants of ring finger protein 213 gene (RNF213) were illustrated as susceptibility variants for …
Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
Newman S, Boulter JH, Malcolm JG, Pradilla I, Pradilla G. Newman S, et al. World Neurosurg. 2020 Mar;135:165-170. doi: 10.1016/j.wneu.2019.11.137. Epub 2019 Nov 29. World Neurosurg. 2020. PMID: 31790841
METHODS: A systematic review was performed including studies with 3 or more participants with moyamoya syndrome in the setting of sickle cell disease and a measured outcome after either medical or surgical intervention. ...Of the patients that underwent indirect rev …
METHODS: A systematic review was performed including studies with 3 or more participants with moyamoya syndrome in the setting of sic …
Central nervous system vasculopathy and Seckel syndrome: case illustration and systematic review.
Khojah O, Alamoudi S, Aldawsari N, Babgi M, Lary A. Khojah O, et al. Childs Nerv Syst. 2021 Dec;37(12):3847-3860. doi: 10.1007/s00381-021-05284-8. Epub 2021 Aug 3. Childs Nerv Syst. 2021. PMID: 34345934 Free PMC article.
RESULTS: The overall rate of CNS vasculopathy in SS patients is 3.16% (n = 8/253), where moyamoya disease (MMD) accounted for 1.97%. The mean age is 13.5 years (6-19 years), with equal gender distribution (M:F, 1:1). ...Regardless of the management approach, …
RESULTS: The overall rate of CNS vasculopathy in SS patients is 3.16% (n = 8/253), where moyamoya disease (MMD) accounted for …
27 results